Universal Health Services, Inc. (NYSE:UHS) Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. boosted its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 49.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 133,261 shares of the health services provider's stock after acquiring an additional 44,173 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.21% of Universal Health Services worth $25,040,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. D. E. Shaw & Co. Inc. boosted its position in shares of Universal Health Services by 99.2% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 12,450 shares of the health services provider's stock worth $2,234,000 after buying an additional 6,200 shares during the period. Smartleaf Asset Management LLC boosted its position in shares of Universal Health Services by 30.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 455 shares of the health services provider's stock worth $81,000 after buying an additional 107 shares during the period. Cetera Investment Advisers boosted its position in shares of Universal Health Services by 30.6% during the fourth quarter. Cetera Investment Advisers now owns 12,858 shares of the health services provider's stock worth $2,307,000 after buying an additional 3,011 shares during the period. SG Americas Securities LLC purchased a new position in shares of Universal Health Services during the first quarter worth $1,141,000. Finally, CX Institutional purchased a new position in shares of Universal Health Services during the first quarter worth $74,000. 86.05% of the stock is currently owned by hedge funds and other institutional investors.

Universal Health Services Stock Up 0.4%

Universal Health Services stock opened at $178.15 on Friday. Universal Health Services, Inc. has a 1-year low of $153.99 and a 1-year high of $243.25. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.32 and a quick ratio of 1.23. The stock has a market cap of $11.58 billion, a PE ratio of 10.00, a P/E/G ratio of 0.72 and a beta of 1.31. The stock's fifty day moving average is $180.83 and its two-hundred day moving average is $181.36.

Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings results on Monday, April 28th. The health services provider reported $4.84 earnings per share for the quarter, beating analysts' consensus estimates of $4.36 by $0.48. Universal Health Services had a return on equity of 17.79% and a net margin of 7.44%. The company had revenue of $4.10 billion for the quarter, compared to analysts' expectations of $4.16 billion. During the same period last year, the firm earned $3.70 earnings per share. Universal Health Services's quarterly revenue was up 6.7% on a year-over-year basis. On average, sell-side analysts expect that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

Universal Health Services Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Monday, June 2nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date was Monday, June 2nd. Universal Health Services's dividend payout ratio is presently 4.49%.

Insider Buying and Selling at Universal Health Services

In other news, Director Maria Ruderman Singer sold 1,097 shares of Universal Health Services stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $191.48, for a total transaction of $210,053.56. Following the sale, the director now owns 7,884 shares in the company, valued at approximately $1,509,628.32. The trade was a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 16.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UHS has been the subject of several research analyst reports. Baird R W lowered Universal Health Services from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Stephens upgraded Universal Health Services to a "hold" rating in a research report on Monday, June 2nd. Barclays lifted their target price on Universal Health Services from $249.00 to $257.00 and gave the company an "overweight" rating in a report on Tuesday, April 29th. Royal Bank Of Canada decreased their target price on Universal Health Services from $211.00 to $201.00 and set a "sector perform" rating for the company in a report on Wednesday, April 30th. Finally, Morgan Stanley started coverage on Universal Health Services in a report on Wednesday, March 26th. They issued an "equal weight" rating and a $200.00 target price for the company. Nine analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Universal Health Services presently has a consensus rating of "Hold" and a consensus price target of $224.77.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.